The primary focus of our research effort is to create a safe, effective and wholly beneficial therapeutic that can improve the lives of those suffering from metabolic disorders.

Our fundamental research principal is based on the “ADME” process. This drug development approach focuses on Absorption, Distribution, Metabolism and Excretion as the four main cornerstones to creating safer and more effective therapeutics.

Using this research platform allows us to rapidly search global and remote sources for promising drug leads. Once our team has identified a lead we then begin work on rapid identification and isolation for pre-clinical screening. Next our library of drug candidates are then run through a series of in vitro analysis to quantify and better understand the candidates interactions in the metabolic pathway and how they might be applied to a therapeutic. This includes toxicology, physiological, metabolic profiling and classification.

The photochemical properties of the world’s plant biota’s can provide us with an almost endless supply of safe drug candidates that are just waiting discovery.